成功治疗了C3球粒细胞病变,其中蛋白质和遗传分析对诊断有用
Motoko Kanzaki1, Motoyasu Kurahashi2, Kentaro Watanabe2
1Department of Nephrology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, 710-8602, Japan. mk14727@kchnet.or.jp.
CEN case reports
|September 12, 2024
概括
一种罕见的炎 - - C3球囊病,涉及补体调节失调. 这项案例研究表明,皮质类固醇有效地治疗了患有自身抗体驱动的C3球体病变的患者,并实现了完全缓解.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 补充系统生物学 补充系统生物学
背景情况:
- C3球囊病是一种罕见的脏疾病,其特点是球囊中C3沉积,这是由补体调节失调引起的.
- 致病性往往涉及替代补充路径失调和终端路径激活,经常是由自抗体等获得因素驱动的.
研究的目的:
- 报告通过脏活检诊断的C3球囊病变病例.
- 研究补充和遗传因素在疾病中的作用.
- 为了评估对皮质类固醇的治疗反应.
主要方法:
- 脏活检用于诊断.
- 对血清补充水平 (C3,sC5b-9) 和与补充相关的蛋白质的分析.
- 补充相关基因的遗传分析.
主要成果:
- 患者在接受皮质类固醇治疗两个月内实现了完全缓解.
- 实验室发现包括低C3水平和高可溶性终端通路蛋白质复合体 (sC5b-9).
- 在补体相关基因中没有发现任何致病变体,支持自身抗体介导的病因学.
结论:
- 这名患者被诊断出患有与自身抗体相关的C3型血小板病.
- 皮质类固醇治疗显示出显著的疗效,支持了诊断和治疗策略.
- 补充和遗传分析对于理解C3球囊病变的发病因子和指导治疗至关重要.
相关概念视频
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Nephrotic Syndrome II : Assessment and Medical Management
409
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409
Chronic Kidney Disease III: Interprofessional Care
679
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679


